US Experience With Infliximab Biosimilars Suggests Need for More Development IncentivesAugust 13, 2024PediatricsDermatologyGastroenterologyMusculoskeletal DisordersRheumatology
Remission or Not, Biologics May Mitigate Cardiovascular Risks of RAAugust 13, 2024RheumatologyCardiologyPreventive Care
Are Your Patients Using Any of These Six Potentially Hepatotoxic Botanicals?August 12, 2024HepatologyGastroenterologyRheumatologyOsteoarthritisPreventive Care
High Prevalence of Anxiety, Depression, Fibromyalgia With RA and OA Signals Need for ScreeningAugust 2, 2024OsteoarthritisRheumatology
Study Finds Differences in Side Effect Profiles With Two Oral Psoriasis TherapiesJuly 26, 2024DermatologyRheumatology
Risk of MACE Comparable Among Biologic Classes for Psoriasis, PsAJuly 26, 2024Mixed TopicsDermatologyCardiologyRheumatology
New Drugs, Treatment Strategies Aim to Lessen Rheumatic Diseases’ Reliance on SteroidsJuly 25, 2024Rheumatology
Mysteries Persist About Tissue Resident Memory T Cells in PsoriasisJuly 25, 2024DermatologyRheumatology
Debate: Should Dermatologists or Rheumatologists Manage Musculoskeletal Symptoms in Patients With Psoriasis?July 23, 2024DermatologyRheumatology
Meet the Pregnancy Challenges of Women With Chronic ConditionsJuly 16, 2024Preventive CareDiabetesObesityWomen's HealthRheumatology
